HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

László Vécsei Selected Research

Excitatory Amino Acid Antagonists

12/2020Sensitivity of Rodent Microglia to Kynurenines in Models of Epilepsy and Inflammation In Vivo and In Vitro: Microglia Activation is Inhibited by Kynurenic Acid and the Synthetic Analogue SZR104.
1/2019The Therapeutic Impact of New Migraine Discoveries.
1/2018Ischemic Stroke and Kynurenines: Medicinal Chemistry Aspects.
1/2016Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System.
11/2013Kynurenines and other novel therapeutic strategies in the treatment of dementia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


László Vécsei Research Topics

Disease

43Migraine Disorders (Migraine)
01/2022 - 04/2004
34Parkinson Disease (Parkinson's Disease)
01/2022 - 07/2003
32Multiple Sclerosis
03/2022 - 05/2006
21Neurodegenerative Diseases (Neurodegenerative Disease)
06/2022 - 07/2005
19Pain (Aches)
07/2021 - 01/2009
18Huntington Disease (Huntington's Disease)
09/2020 - 09/2002
16Headache (Headaches)
10/2021 - 09/2006
14Alzheimer Disease (Alzheimer's Disease)
01/2022 - 07/2005
12Neuroinflammatory Diseases
01/2022 - 11/2009
11Epilepsy (Aura)
01/2021 - 07/2005
10Nervous System Diseases (Neurological Disorders)
01/2021 - 07/2005
9Ischemic Stroke
12/2021 - 05/2008
9Inflammation (Inflammations)
10/2021 - 08/2010
8Schizophrenia (Dementia Praecox)
01/2022 - 05/2017
8Stroke (Strokes)
10/2021 - 07/2005
8Mitochondrial Diseases (Mitochondrial Disease)
10/2021 - 06/2007
8Dyskinesias (Dyskinesia)
11/2016 - 01/2004
7Relapsing-Remitting Multiple Sclerosis
05/2022 - 05/2006
6Disease Progression
01/2022 - 03/2013
6Mental Disorders (Mental Disorder)
07/2021 - 02/2012
6Dementia (Dementias)
01/2020 - 11/2013
5Neurogenic Inflammation
12/2021 - 04/2004
5Brain Ischemia (Cerebral Ischemia)
10/2021 - 09/2003
5Autoimmune Diseases (Autoimmune Disease)
12/2020 - 01/2013
4Cognitive Dysfunction
07/2021 - 01/2013
4Atrophy
07/2016 - 07/2003
3Chronic Progressive Multiple Sclerosis
01/2022 - 03/2009
3Demyelinating Diseases (Demyelinating Disease)
02/2021 - 05/2011
3Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
03/2020 - 11/2016
3Movement Disorders (Movement Disorder)
01/2018 - 07/2003
3Pathologic Processes
08/2015 - 04/2011
3Ischemia
09/2011 - 06/2007
2Immune System Diseases (Immune Disorders)
03/2022 - 11/2017
2Edema (Dropsy)
12/2021 - 01/2021
2Chronic Pain
07/2021 - 07/2003
2Prodromal Symptoms
06/2021 - 01/2016
2Asphyxia (Suffocation)
05/2021 - 12/2017
2Hypothermia
05/2021 - 12/2015
2Sepsis (Septicemia)
01/2021 - 01/2020
2Brain Injuries (Brain Injury)
01/2021 - 10/2010
2Peritonitis
01/2021 - 01/2020
2Neoplasms (Cancer)
12/2020 - 11/2020

Drug/Important Bio-Agent (IBA)

41KynurenineIBA
03/2022 - 06/2007
32Kynurenic Acid (Kynurenate)IBA
09/2021 - 09/2003
18Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2009
18Glutamic Acid (Glutamate)FDA Link
06/2021 - 02/2009
16Tryptophan (L-Tryptophan)FDA Link
10/2021 - 02/2010
16Pharmaceutical PreparationsIBA
01/2021 - 05/2010
14N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
03/2021 - 04/2004
13Levodopa (L Dopa)FDA LinkGeneric
01/2020 - 01/2005
12EnzymesIBA
12/2021 - 07/2003
10Calcitonin Gene-Related PeptideIBA
01/2022 - 01/2009
10Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
06/2021 - 02/2012
9NeuropeptidesIBA
12/2021 - 07/2003
8CytokinesIBA
10/2021 - 02/2012
8Neuroprotective AgentsIBA
01/2021 - 09/2003
8Proteins (Proteins, Gene)FDA Link
03/2020 - 06/2005
8Glutamate Receptors (Glutamate Receptor)IBA
09/2019 - 09/2002
8N-Methylaspartate (NMDA)IBA
01/2018 - 06/2007
7Nitroglycerin (Dynamite)FDA LinkGeneric
11/2017 - 11/2006
5Monoamine Oxidase (MAO)IBA
01/2022 - 05/2013
5Tryptamines (Triptans)IBA
01/2022 - 06/2015
5Messenger RNA (mRNA)IBA
10/2021 - 11/2007
5Excitatory Amino Acid AntagonistsIBA
12/2020 - 11/2013
5Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2017 - 04/2004
4Selegiline (E250)FDA LinkGeneric
01/2022 - 01/2004
4Monoclonal AntibodiesIBA
01/2022 - 03/2013
4AntibodiesIBA
01/2022 - 05/2006
4Serotonin (5 Hydroxytryptamine)IBA
10/2021 - 11/2014
4Interleukin-6 (Interleukin 6)IBA
01/2021 - 09/2012
4SZR 72IBA
01/2021 - 12/2015
4Type A Botulinum Toxins (Botox)FDA Link
01/2019 - 03/2012
4Formaldehyde (Formol)FDA Link
01/2018 - 01/2015
4Adenosine Triphosphate (ATP)IBA
11/2013 - 06/2007
3teriflunomideIBA
05/2022 - 03/2015
3Neurotransmitter Agents (Neurotransmitter)IBA
12/2021 - 03/2012
3Peroxidase (Myeloperoxidase)IBA
01/2021 - 08/2012
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 03/2009
3EndocannabinoidsIBA
10/2019 - 08/2016
3Dopamine (Intropin)FDA LinkGeneric
11/2018 - 01/2005
3Peptides (Polypeptides)IBA
03/2018 - 08/2010
3Adenylyl Cyclases (Adenylyl Cyclase)IBA
03/2018 - 12/2016
3NeurotoxinsIBA
02/2017 - 09/2002
3Carbidopa (Lodosyn)FDA LinkGeneric
01/2017 - 03/2014
3Substance PIBA
08/2015 - 03/2012
2ChromatinIBA
01/2022 - 06/2005
2Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
01/2022 - 01/2015
2Fingolimod Hydrochloride (FTY720)FDA Link
01/2022 - 03/2012
2Memantine (Namenda)FDA Link
01/2022 - 01/2016
2Biological ProductsIBA
07/2021 - 03/2021
2MelatoninIBA
06/2021 - 06/2020
2Hormones (Hormone)IBA
06/2021 - 01/2018
2anthranilic acid (anthranilate)IBA
06/2021 - 06/2020
2picolinic acid (chromium picolinate)IBA
06/2021 - 06/2020
2Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
03/2021 - 02/2012
2salicylhydroxamic acid (SHAM)IBA
01/2021 - 01/2020
2Sirtuin 1IBA
01/2021 - 09/2020
2CalciumIBA
12/2020 - 01/2018
2entacapone (Comtan)FDA Link
12/2020 - 05/2009

Therapy/Procedure

47Therapeutics
01/2022 - 07/2003